Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Short-Term Debt repayments: 2021-2022

  • Aytu Biopharma's Short-Term Debt repayments fell 33.11% to $30.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $163.5 million, marking a year-over-year change of. This contributed to the annual value of $156.4 million for FY2022, which is 189.66% up from last year.
  • According to the latest figures from Q3 2022, Aytu Biopharma's Short-Term Debt repayments is $30.5 million, which was down 22.44% from $39.3 million recorded in Q2 2022.
  • In the past 5 years, Aytu Biopharma's Short-Term Debt repayments ranged from a high of $48.0 million in Q2 2021 and a low of $30.5 million during Q3 2022.
  • Moreover, its 2-year median value for Short-Term Debt repayments was $42.5 million (2021), whereas its average is $40.9 million.
  • Data for Aytu Biopharma's Short-Term Debt repayments shows a maximum YoY crashed of 33.11% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows Aytu Biopharma's Short-Term Debt repayments stood at $45.6 million in 2021, then plummeted by 33.11% to $30.5 million in 2022.
  • Its Short-Term Debt repayments stands at $30.5 million for Q3 2022, versus $39.3 million for Q2 2022 and $45.6 million for Q3 2021.